6.69
전일 마감가:
$7.36
열려 있는:
$7.25
하루 거래량:
106.93K
Relative Volume:
0.91
시가총액:
$78.85M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-10.14
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
-19.30%
1개월 성능:
+22.98%
6개월 성능:
+16.35%
1년 성능:
-19.30%
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DTIL
Precision Biosciences Inc
|
6.69 | 86.75M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunitySell Signal & Capital Efficiency Focused Ideas - newser.com
Will Precision BioSciences Inc. outperform the marketTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Precision BioSciences: Q3 Earnings Snapshot - CT Insider
Real time breakdown of Precision BioSciences Inc. stock performanceExit Point & Verified High Yield Trade Plans - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economyPrice Action & Verified High Yield Trade Plans - newser.com
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Multi asset correlation models including Precision BioSciences Inc.Earnings Performance Report & Technical Pattern Alert System - newser.com
Is Precision BioSciences Inc. stock a defensive play in 20252025 Support & Resistance & High Yield Stock Recommendations - newser.com
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - TradingView
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
How Precision BioSciences Inc. stock trades during market volatilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Has Precision BioSciences Inc. found a price floorJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks
Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryDollar Strength & Entry and Exit Point Strategies - newser.com
Imugene to Issue 19.5 Million Shares, Pay $3 Million in Cash to Precision Biosciences as Milestone Payment Under Licensing Agreement - MarketScreener
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidate2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news
Why millennials buy Precision BioSciences Inc. (PBS0) stockMarket Activity Recap & Weekly Momentum Picks - newser.com
Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance
A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st
Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):